iAs always, the competition was sharp, but the accountants, made up of teams from PwC and the FCA, have counted the votes several times and declared, "Eh, close enough."

In August 2015 AIM Casino listed fraud Eden Research (EDEN) announced that it had sold a license to its long time associated company Terpenetech for £600,000. On the same day it announced that it had bought a 29% stake in (worthless) Terpenetech for £920,000 in shares. I quizzed Eden's PR man Paul "Queenie" McManus of Walbrook PR about this deal which was clearly a panama pump fraud. And Queenie lied to me.

Hello Share Squirters. As I get older, I become more fearful about my health. Apart from a minor problem with the old prostate, I am not yet troubled by illness. But I think disaster may be around the corner, especially if I do not watch my diet and take preventative steps to slow down wearing out. So it would only be fair to consider buying shares in a company which fulfils those needs.

The starting gun on the next general election has been fired so unexpectedly that the report has been felt throughout the country. But the first tangible response was a swift rally in the pound, putting pressure on the UK stock market.

This week's sponsor, Eden Research (EDEN), has much to offer the thinking investor. Well that is if you like investing in proven frauds that wil never generate a cent of free cashflow without resorting to the panama pump.

Having punched a bit under the belt yesterday with a dig at potential insolvency at the UK subsidiary, I thought I would bring some great news to CloudTag (CTAG) shareholders. Amit Ben-Haim appears to have seen the error of his ways and ditched all other directorships so that he can now solely focus on generating shareholder value at CloudTag. Can’t think of any other explanation….

More details of how Aussie poltroons Slater & Gordon (SGH) is suing Watchstone (WTG), Quenron (QPP) as was, for £600 million have emerged in the Aussie press. And for Britain's biggest fraudster of the past 30 years, already under SFO investigation, it is not good news. And top of the morning it is to you Robert Simon Terry.

It is extremely rare for companies to resort to death spiral financing without serious damage to their share price (Gulf Keystone pulled it off a few years ago, but it really doesn’t happen often). Mongolian oil explorer Petro Matad (MATD) is unlikely to be an exception to this rule.

Andrews Sykes (ASY), a 380p offer price November share tip, has announced results for the 2016 calendar year and that it is “cautiously optimistic for further success in 2017”…

Marcus Stuttard, head of AIM and the oxymorons of AIM Regulation, had a specially selected and beautifully diversified portfolio of AIM stocks chosen by ShareProphets back at the end of last September so that he could demonstrate his faith in the regulatory set-up of the market he runs. Naturally, there was nothing at all wrong with any of the companies picked: they were all trading on the Casino as normal, so we were just plain wrong to be Red Flagging them all for one reason or another.  We were just so, so wrong that……

I asked my very good pals at the Financial Reporting Council, who we know are major fans of my work, to look into the fraudulent accounts of Eden Research (EDEN) for 2011, 2012, 2013, 2014 and 2015 on February 17 2016. Okay 2015 accounts were not out at that point but I was sure they would be fraudulent - they were. Now 2016 accounts for Terpenetech are out we have it again confirmed that the 2015 accounts were crook and 2016 accounts - due within days - will almost certainly be fraudulent. So I have written to the FRC again. The letter follows.

There were spectacular gains in gold and silver last year and that has affected people’s expectations since most of those gains have now been given up. In the near term we will likely test support at $16 silver and $1200 for gold - that is the warning from gold guru Brad Cooke. But... The Fed has set a course of quarterly rate increases that is faster than economic growth which is a formula for stagflation and recession, when this happens investors holding gold and silver investments will do well.

Well, the first non-Tom article is by me, at a lofty #4: Leavers are either nuts or hiding what they're really on about. There, I said it. To be honest, I still haven't received a satisfying answer in the comments.

Despite the nonsense spouted by AberdeenMan, Mr Selfridge and BrokerMan1 on LSE about CloudTag (CTAG) and its bright prospects, confirmation that the end is nigh has reached Companies House with the CEO, Amit Ben-Haim, stepping off the board of CloudTag’s UK subsidiary and being replaced by the Grim Reaper himself, Massimo Ventimiglia.

The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.

There were many fine entries for the Jezza caption contest, but there can only be one winner.

We are now way ahead on this share tip which was at a 6.75p offer. The shares are now 15.25p-16p on the back of a very bullish trading statement. But before you think about taking profits on Symphony Environmental (SYM) remember that the market cap is still just £23.6 million.

I spend most of my time being critical of companies that issue RNS’s containing half-truths, exaggerations or are just an opaque mess. However, a week ago, I read an RNS which impressed me for being just the opposite. It persuaded me to do further research which has led to this very rare beast – a buy tip….for Frontier Smart Technologies (FST).